Company
TerrAscend Corp
Headquarters: Mississauga, ON, Canada
Market Cap
C$804.8 Million
CAD as of July 1, 2023
US$607.4 Million
TerrAscend Corp Categories
Canada Healthcare Drug Manufacturers—Specialty & GenericCanada Healthcare Canada Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Detailed Description
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. It produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis infused artisan edibles. The company also operates three retail dispensaries under the Apothecarium brand name in California and Pennsylvania. TerrAscend Corp. was incorporated in 2017 and is based in Mississauga, Canada.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Stocks & Indices
TerrAscend Corp has the following listings and related stock indices.
Stock: TSX: TSND wb_incandescent
Stock: CSE: TER wb_incandescent
Stock: FSX: TED wb_incandescent
Stock: OTC: TRSSF wb_incandescent